CATX:NYSEAMERICAN
Perspective Therapeutics Inc
2,72 USD
arrow_downward
-1,09%(-0,030) 1D
2,85 USD
arrow_upward
+4,78% (+0,13)todayPre-market
Closed: 1-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CATX...
Open
2,71 USD
High
2,78 USD
Low
2,66 USD
Mkt. cap
310,49 млн
Avg. vol.
1,85 млн
Volume
4,64 миң
52-wk high
6,16 USD
52-wk low
1,96 USD
EPS
-1,33 USD
Beta
1,80
Shares outstanding
114,15 млн
No. of employees
163
Open
2,71 USD
High
2,78 USD
Low
2,66 USD
Mkt. cap
310,49 млн
Avg. vol.
1,85 млн
Volume
4,64 миң
52-wk high
6,16 USD
52-wk low
1,96 USD
EPS
-1,33 USD
Beta
1,80
Shares outstanding
114,15 млн
No. of employees
163
News stories
From web sources and news partners
TipRanks
·
13 саат мурун
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
Stock Titan
·
13 саат мурун
Three cancer programs are in trials. Perspective Therapeutics (CATX) reports early melanoma results.
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersСиэтл, Вашингтон, Америка Кошмо Штаттары
Sector-
Websiteperspectivetherapeutics.com